As a company that is very conscious of its values,
we feel committed not only to the employees and shareholders
of Merck but also to the community – at all
our sites and worldwide. With the drug Cesol® 600,
Merck has been cooperating with the World Health
Organization since 2007 to fight schistosomiasis, an
infectious disease caused by parasitic worms living in
tropical water. It is estimated that around 200 million
people are infected. Since the donation program began,
Merck has supplied around 80 million tablets to treat
around 19 million children. In 2011 we decided to expand
our engagement tenfold. In the medium term we intend
to provide 250 million tablets per year and to continue
this donation until the disease has been eliminated
in Africa.
We apply all our expertise and skills not only to achieve sustainable entrepreneurial
success, but also to meet our social responsibility.
Taking on responsibility
Merck is supporting
the fight against schistosomiasis, thereby protecting
many children in Africa against this serious disease.